Epidermal growth factor receptor-dependent cytotoxic effect by an EGF—ribonuclease conjugate on human cancer cell lines -A trial for less immunogenic chimeric toxin- Hiromitsu JinnoM. UedaMasaki Kitajima ORIGINAL ARTICLE Pages: 303 - 308
Chromosome Aberrations and pharmacokinetics in patients receiving tauromustine as either a single or a repeated dose B. Hartley-AspK. HanssonP. O. Gunnarsson ORIGINAL ARTICLE Pages: 309 - 316
Histopathological changes in rabbit uterus carcinoma after transcatheter arterial embolization using cisplatin Y. HarimaKeizo HarimaYoshimasa Tanaka ORIGINAL ARTICLE Pages: 317 - 322
A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesis G. S. HarmanGeorge A. OmuraWilliam F. Hahne ORIGINAL ARTICLE Pages: 323 - 328
Preclinical pharmacology of ecteinascidin 729, a marine natural product with potent antitumor activity Joel M. ReidDenise L. WalkerM. M. Ames ORIGINAL ARTICLE Pages: 329 - 334
Antitumor activity of prolonged as compared with bolus administration of 2′,2′-difluorodeoxycytidine in vivo against murine colon tumors Gijsbert VeermanV. W. T. Ruiz van HaperenG. J. Peters ORIGINAL ARTICLE Pages: 335 - 342
Development and validation of a chiral high-performance liquid chromatography assay for rogletimide and rogletimide-N-oxide isomers in plasma M. C. EtienneW. OsterG. Milano ORIGINAL ARTICLE Pages: 343 - 348
Enhancement of melphalan activity by inhibition of DNA polymerase-α and DNA polymerase-β K. MoynihanGertrude B. ElionH. S. Friedman ORIGINAL ARTICLE Pages: 349 - 354
Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent β-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat Jörg StübenRüdiger PortM. Wiessler ORIGINAL ARTICLE Pages: 355 - 365
A novel in vitro model system for studying the action of ara-C Philip WillsRobert HickeyL. Malkas ORIGINAL ARTICLE Pages: 366 - 372
Biological characterization of L-asparaginase liposomal formulations M. M. GasparR. Perez-SolerM. E. M. Cruz ORIGINAL ARTICLE Pages: 373 - 377
Pharmacokinetic evaluation of high-dose etoposide phosphate after a 2-hour infusion in patients with solid tumors W. KreisDaniel R. BudmanScott Z. Fields ORIGINAL ARTICLE Pages: 378 - 384
Multimodal biochemical modulation of 5-fluorouracil by leucovorin, methotrexate, and interferon alpha in patients with advanced colorectal cancer S. CascinuPaolo AlessandroniGiuseppina Catalano CLINICAL TRIAL REPORT Pages: 385 - 386
Unchanged pharmacokinetics of etoposide given by intra-arterial hepatic infusion as compared with i.v. infusion O. van TellingenMaarten T. KuckJos H. Beijnen SHORT COMMUNICATION Pages: 387 - 390
Comparison of ethanol plasma-protein precipitation with plasma ultrafiltration and trichloroacetic acid protein precipitation for the measurement of unbound platinum concentrations Jianguo MaGerrit StoterJ. H. M. Schellens SHORT COMMUNICATION Pages: 391 - 394